Form 4 Filing for Envoy Medical, Inc.

Chas McKhann, a director at Envoy Medical, Inc., acquired 100,000 stock options on April 15, 2026. These options, exercisable at $0.72 per share, are for Class A Common Stock and expire on April 15, 2036. The options will vest monthly over 36 months starting May 15, 2026. Following this transaction, McKhann directly owns 100,000 shares of Class A Common Stock underlying these options. The filing was signed by Andrew Nick as attorney-in-fact for Chas McKhann.